Aquestive Therapeutics, Inc. AQST Pre-Tax Income
Pre-Tax Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s pre-tax income?
- Aquestive Therapeutics, Inc. (AQST) reported pre-tax income of -$8.06M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s pre-tax income changed year-over-year?
- Aquestive Therapeutics, Inc.'s pre-tax income increased by 64.9% year-over-year, from -$22.93M to -$8.06M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s pre-tax income?
- Over 4 years (2021 to 2025), Aquestive Therapeutics, Inc.'s pre-tax income has grown at a 4.4% compound annual growth rate (CAGR), from -$70.54M to -$83.78M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.